Projects

Assessment of muscle strength and its association with physical activity and quality of life of children with chronic kidney disease: a prospective longitudinal study

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2022 - 2025

Project Lead

Dr. Arpana Iyengar

Authors

Dr. Arpana Iyengar

Project Status

completed